With 79% institutional ownership, Stryker Corporation (NYSE: SYK) is a favorite amongst the big guns....
On April 8, 2025, QuantWave, a leading automated forecasting platform, issued a long signal for STRYKER CORPORATION (STK) with a price target forecast of $362.97. The stock was trading at $337....
On April 2, 2025, QuantWave, an automated forecasting platform, issued a short signal for STRYKER CORPORATION with a price target of $345.8....
With a strong track record of innovation and a commitment to providing top-quality medical devices, Stryker Corporation (NYSE:SYK) has become a favorite among investors....
Stryker Corporation, a leading medical technology company, is seeing its NYSE:SYK share price aligning with investor opinions, according to market analysis by Simply Wall St News....
Stryker Corporation, a leading medical technology company, has recently unveiled their next-generation Mako SmartRobotics with an industry-first hip revision capability....
Stryker Corporation, a leading medical technology company, recently showcased its next-generation Mako SmartRobotics at the AAOS 2025 Annual Meeting....
Stryker Corporation, a leading medical technology company, recently announced the release of its next-generation Mako SmartRobotics platform....
Stryker Corporation, a global leader in medical technology, showcased its next generation of Mako SmartRobotics at the AAOS 2025 Annual Meeting....
Medical technology giant Stryker Corporation (NYSE:SYK) has made waves in the healthcare industry once again by unveiling its latest innovation - the next-generation Mako SmartRobotics system for hip revision. This cutting-edge robotic system is set to revolutionize the way hip revision surgeries are performed. The Mako SmartRobotics system offers unprecedented precision and accuracy, reducing the...